Study Comparing RT With Cetuximab + Xevinapant to RT With Cetuximab-placebo in Patients With Head and Neck Cancer

Clinical trial NCT05930938 · TERMINATED

Trial details

NCT number: NCT05930938
Sponsor: Groupe Oncologie Radiotherapie Tete et Cou
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2023-12-12
Primary completion: 2024-09-30
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.